Frédérique Menzaghi
2013
In 2013, Frédérique Menzaghi earned a total compensation of $305K as Vice President - Research and Development at Cara Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $30,000 |
|---|---|
| Salary | $275,000 |
| Total | $305,000 |
Menzaghi received $275K in salary, accounting for 90% of the total pay in 2013.
Menzaghi also received $30K in non-equity incentive plan.
Rankings
In 2013, Frédérique Menzaghi's compensation ranked 10,798th out of 12,286 executives tracked by ExecPay. In other words, Menzaghi earned more than 12.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,798 out of 12,286 | 12th |
Division Manufacturing | 4,028 out of 4,612 | 13th |
Major group Chemicals And Allied Products | 1,272 out of 1,462 | 13th |
Industry group Drugs | 1,006 out of 1,156 | 13th |
Industry Pharmaceutical Preparations | 783 out of 890 | 12th |
Source: SEC filing on April 24, 2015.
Menzaghi's colleagues
We found two more compensation records of executives who worked with Frédérique Menzaghi at Cara Therapeutics in 2013.
News
Cara Therapeutics CEO Derek Chalmers' 2021 pay jumps 250% to $10M
April 22, 2022
Cara Therapeutics CEO Derek Chalmers' 2020 pay slips 15% to $2.9M
April 23, 2021
Cara Therapeutics CEO Derek Chalmers' 2019 pay jumps 23% to $3.4M
April 22, 2020
Cara Therapeutics Chief Medical Officer Joana Goncalves receives $3.7M in 2018
April 24, 2019